These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ergotamine tartrate dependency: features and possible mechanisms. Saper JR; Jones JM Clin Neuropharmacol; 1986; 9(3):244-56. PubMed ID: 3087616 [TBL] [Abstract][Full Text] [Related]
4. [Risks related to the use of ergotamine in the therapy of hemicrania. Description of a case]. Bocchia M; Baldini GG; Bertola G; Zorzoli C Recenti Prog Med; 1991; 82(7-8):390-3. PubMed ID: 1947404 [TBL] [Abstract][Full Text] [Related]
5. Vascular injuries in ergotamine abuse: a case report. Centonze V; Polito BM; Di Bari M; Caporaletti P; Albano O Funct Neurol; 1993; 8(4):265-70. PubMed ID: 8314118 [TBL] [Abstract][Full Text] [Related]
7. ['Only ergotamine still helps']. Ferrari MD; Mulder LJ Ned Tijdschr Geneeskd; 1991 Jul; 135(27):1209-11. PubMed ID: 1861750 [No Abstract] [Full Text] [Related]
8. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Meskunas CA; Tepper SJ; Rapoport AM; Sheftell FD; Bigal ME Headache; 2006 May; 46(5):766-72. PubMed ID: 16643579 [TBL] [Abstract][Full Text] [Related]
9. Hypnic headache associated with medication overuse: case report. Baykan B; Ertaş M Agri; 2008 Jul; 20(3):40-3. PubMed ID: 19085181 [TBL] [Abstract][Full Text] [Related]
10. [Drug dependence and withdrawal in chronic pain patients]. Wörz R Fortschr Med; 1994 Jun; 112(16):229-31. PubMed ID: 8070745 [TBL] [Abstract][Full Text] [Related]
11. Ergotamine tartrate in the treatment of migraine. Wilkinson M; Wall WC Arch Neurobiol (Madr); 1974; 37 SUPPL():317-9. PubMed ID: 4462488 [No Abstract] [Full Text] [Related]
12. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes. Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858 [TBL] [Abstract][Full Text] [Related]
13. Ergotamine tartrate in migraine and the dangers of overdose. Wall MC Nurs Times; 1972 Dec; 68(50):1585. PubMed ID: 4640242 [No Abstract] [Full Text] [Related]
14. Systemic availability of ergotamine tartrate in continuous medication. Myllylä VV; Ala-Hurula V; Arvela P; Kärki N; Hokkanen E Ups J Med Sci Suppl; 1980; 31():20-2. PubMed ID: 6935854 [TBL] [Abstract][Full Text] [Related]
16. [Ergotamine; from headache to heartache]. Slob J; Burgersdijk C; Ruiter JH Ned Tijdschr Geneeskd; 1988 May; 132(20):927-30. PubMed ID: 3374687 [No Abstract] [Full Text] [Related]
17. Arterial response to ergotamine tartrate in abusing and non-abusing migraine patients. Tfelt-Hansen P; Olesen J Acta Pharmacol Toxicol (Copenh); 1981 Jan; 48(1):69-72. PubMed ID: 6784444 [TBL] [Abstract][Full Text] [Related]
18. [Use of ergotamine tartrate as a suppository in migraine]. Dalsgaard-Nielsen T Nord Med; 1968 Jul; 80(29):942-4. PubMed ID: 5685659 [No Abstract] [Full Text] [Related]
19. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up. Schnider P; Aull S; Baumgartner C; Marterer A; Wöber C; Zeiler K; Wessely P Cephalalgia; 1996 Nov; 16(7):481-5; discussion 461. PubMed ID: 8933992 [TBL] [Abstract][Full Text] [Related]
20. [Ergotamine addiction in migraine patients]. Retterstol N Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2122. PubMed ID: 4773989 [No Abstract] [Full Text] [Related] [Next] [New Search]